The DOI matches its Crossref record; 245 of the 245 references it cites were found in a registry or an index.
Broad-spectrum agents for flaviviral infections: dengue, Zika and beyond
Open accessAbstract
Flaviviruses, including dengue and Zika viruses, are of substantial public health concern. Klein and colleagues review the development of broad-spectrum antiviral agents that would target many of the known and potentially unknown flaviviruses. The benefits and caveats of molecules that target either viral proteins or host mechanisms exploited by these viruses are discussed. Infections with flaviviruses, such as dengue, West Nile virus and the recently re-emerging Zika virus, are an increasing and probably lasting global risk. This Review summarizes and comments on the opportunities for broad-spectrum agents that are active against multiple flaviviruses. Broad-spectrum activity is particularly desirable to prepare for the next flaviviral epidemic, which could emerge from as-yet unknown or neglected viruses. Potential molecular targets for broad-spectrum antiflaviviral compounds include viral proteins, such as the viral protease or polymerase, and host targets that are exploited by these viruses during entry and replication, including α-glucosidase and proteins involved in nucleoside biosynthesis. Numerous compounds with broad-spectrum antiviral activity have already been identified by target-specific or phenotypic assays. For other compounds, broad-spectrum activity can be anticipated because of their mode of action and molecular targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global distribution and burden of dengue
Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., Drake, J. M., Brownstein, J. S., Hoen, A. G., Sankoh, O., et al. (2013) · Nature · doi:10.1038/nature12060 · Cited by 10,037
The HCV Life Cycle: In vitro Tissue Culture Systems and Therapeutic Targets
Gerold, G., & Pietschmann, T. (2014) · Digestive Diseases · doi:10.1159/000360830 · Cited by 4,854
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
Wakita, T., Pietschmann, T., Kato, T., Date, T., Miyamoto, M., Zhao, Z., Murthy, K., Habermann, A., Kräusslich, H.-G., Mizokami, M., et al. (2005) · Nature Medicine · doi:10.1038/nm1268 · Cited by 2,754
Zika Virus Infection in Pregnant Women in Rio de Janeiro
Brasil, P., Pereira, J. P., Moreira, M. E., Ribeiro Nogueira, R. M., Damasceno, L., Wakimoto, M., Rabello, R. S., Valderramos, S. G., Halai, U.-A., Salles, T. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602412 · Cited by 2,196
The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution
Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., & Harrison, S. C. (1995) · Nature · doi:10.1038/375291a0 · Cited by 1,437
Approved Antiviral Drugs over the Past 50 Years
De Clercq, E., & Li, G. (2016) · Clinical Microbiology Reviews · doi:10.1128/cmr.00102-15 · Cited by 1,430
The Brazilian Zika virus strain causes birth defects in experimental models
Cugola, F. R., Fernandes, I. R., Russo, F. B., Freitas, B. C., Dias, J. L. M., Guimarães, K. P., Benazzato, C., Almeida, N., Pignatari, G. C., Romero, S., et al. (2016) · Nature · doi:10.1038/nature18296 · Cited by 1,326
First report of autochthonous transmission of Zika virus in Brazil
Zanluca, C., Melo, V. C. A. D., Mosimann, A. L. P., Santos, G. I. V. D., Santos, C. N. D. D., & Luz, K. (2015) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760150192 · Cited by 1,320
Mackenzie, J. S., Gubler, D. J., & Petersen, L. R. (2004) · Nature Medicine · doi:10.1038/nm1144 · Cited by 1,314
Structure of the dengue virus envelope protein after membrane fusion
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2004) · Nature · doi:10.1038/nature02165 · Cited by 1,203
Potential Sexual Transmission of Zika Virus
Musso, D., Roche, C., Robin, E., Nhan, T., Teissier, A., & Cao-Lormeau, V.-M. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2102.141363 · Cited by 1,176
Probable Non–Vector-borne Transmission of Zika Virus, Colorado, USA
Foy, B. D., Kobylinski, K. C., Foy, J. L. C., Blitvich, B. J., Travassos da Rosa, A., Haddow, A. D., Lanciotti, R. S., & Tesh, R. B. (2011) · Emerging Infectious Diseases · doi:10.3201/eid1705.101939 · Cited by 1,156
Mutation rates among RNA viruses
Drake, J. W., & Holland, J. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13910 · Cited by 1,143
Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease
Hadinegoro, S. R., Arredondo-García, J. L., Capeding, M. R., Deseda, C., Chotpitayasunondh, T., Dietze, R., Hj Muhammad Ismail, H. I., Reynales, H., Limkittikul, K., Rivera-Medina, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1506223 · Cited by 1,077
A ligand-binding pocket in the dengue virus envelope glycoprotein
Modis, Y., Ogata, S., Clements, D., & Harrison, S. C. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0832193100 · Cited by 1,061
Oehler, E., Watrin, L., Larre, P., Leparc-Goffart, I., Lastère, S., Valour, F., Baudouin, L., Mallet, H. P., Musso, D., & Ghawche, F. (2014) · Eurosurveillance · doi:10.2807/1560-7917.es2014.19.9.20720 · Cited by 1,016
Reduced Food Intake and Body Weight in Mice Treated with Fatty Acid Synthase Inhibitors
Loftus, T. M., Jaworsky, D. E., Frehywot, G. L., Townsend, C. A., Ronnett, G. V., Lane, M. D., & Kuhajda, F. P. (2000) · Science · doi:10.1126/science.288.5475.2379 · Cited by 1,004
Nucleotide Sequence of Yellow Fever Virus: Implications for Flavivirus Gene Expression and Evolution
Rice, C. M., Lenches, E. M., Eddy, S. R., Shin, S. J., Sheets, R. L., & Strauss, J. H. (1985) · Science · doi:10.1126/science.4023707 · Cited by 961
Association between Zika virus and microcephaly in French Polynesia, 2013–15: a retrospective study
Cauchemez, S., Besnard, M., Bompard, P., Dub, T., Guillemette-Artur, P., Eyrolle-Guignot, D., Salje, H., Van Kerkhove, M. D., Abadie, V., Garel, C., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00651-6 · Cited by 945
Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., Puttikhunt, C., Edwards, C., Duangchinda, T., Supasa, S., et al. (2010) · Science · doi:10.1126/science.1185181 · Cited by 943
Dejnirattisai, W., Supasa, P., Wongwiwat, W., Rouvinski, A., Barba-Spaeth, G., Duangchinda, T., Sakuntabhai, A., Cao-Lormeau, V.-M., Malasit, P., Rey, F. A., et al. (2016) · Nature Immunology · doi:10.1038/ni.3515 · Cited by 914
A Mouse Model of Zika Virus Pathogenesis
Lazear, H. M., Govero, J., Smith, A. M., Platt, D. J., Fernandez, E., Miner, J. J., & Diamond, M. S. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.03.010 · Cited by 909
Cirak, S., Arechavala-Gomeza, V., Guglieri, M., Feng, L., Torelli, S., Anthony, K., Abbs, S., Garralda, M. E., Bourke, J., Wells, D. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60756-3 · Cited by 878
Sabchareon, A., Wallace, D., Sirivichayakul, C., Limkittikul, K., Chanthavanich, P., Suvannadabba, S., Jiwariyavej, V., Dulyachai, W., Pengsaa, K., Wartel, T. A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61428-7 · Cited by 818
Zika Virus Infection during Pregnancy in Mice Causes Placental Damage and Fetal Demise
Miner, J. J., Cao, B., Govero, J., Smith, A. M., Fernandez, E., Cabrera, O. H., Garber, C., Noll, M., Klein, R. S., Noguchi, K. K., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.008 · Cited by 812
Transmission cycles, host range, evolution and emergence of arboviral disease
Weaver, S. C., & Barrett, A. D. T. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1006 · Cited by 715
Zika virus: History, emergence, biology, and prospects for control
Weaver, S. C., Costa, F., Garcia-Blanco, M. A., Ko, A. I., Ribeiro, G. S., Saade, G., Shi, P.-Y., & Vasilakis, N. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.03.010 · Cited by 653
Self-citationXu, M., Lee, E. M., Wen, Z., Cheng, Y., Huang, W.-K., Qian, X., TCW, J., Kouznetsova, J., Ogden, S. C., Hammack, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4184 · Cited by 641
Munger, J., Bennett, B. D., Parikh, A., Feng, X.-J., McArdle, J., Rabitz, H. A., Shenk, T., & Rabinowitz, J. D. (2008) · Nature Biotechnology · doi:10.1038/nbt.1500 · Cited by 635
Egloff, M.-P. (2002) · The EMBO Journal · doi:10.1093/emboj/21.11.2757 · Cited by 613
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Warren, T. K., Wells, J., Panchal, R. G., Stuthman, K. S., Garza, N. L., Van Tongeren, S. A., Dong, L., Retterer, C. J., Eaton, B. P., Pegoraro, G., et al. (2014) · Nature · doi:10.1038/nature13027 · Cited by 610
Dengue Virus Capsid Protein Usurps Lipid Droplets for Viral Particle Formation
Samsa, M. M., Mondotte, J. A., Iglesias, N. G., Assunção-Miranda, I., Barbosa-Lima, G., Da Poian, A. T., Bozza, P. T., & Gamarnik, A. V. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000632 · Cited by 586
Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus
Erbel, P., Schiering, N., D'Arcy, A., Renatus, M., Kroemer, M., Lim, S. P., Yin, Z., Keller, T. H., Vasudevan, S. G., & Hommel, U. (2006) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1073 · Cited by 583
Heaton, N. S., Perera, R., Berger, K. L., Khadka, S., LaCount, D. J., Kuhn, R. J., & Randall, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010811107 · Cited by 566
Nitazoxanide: A first-in-class broad-spectrum antiviral agent
Rossignol, J.-F. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.07.014 · Cited by 556
Mechanisms of action of ribavirin against distinct viruses
Graci, J. D., & Cameron, C. E. (2006) · Reviews in Medical Virology · doi:10.1002/rmv.483 · Cited by 549
Structural basis of potent Zika–dengue virus antibody cross-neutralization
Barba-Spaeth, G., Dejnirattisai, W., Rouvinski, A., Vaney, M.-C., Medits, I., Sharma, A., Simon-Lorière, E., Sakuntabhai, A., Cao-Lormeau, V.-M., Haouz, A., et al. (2016) · Nature · doi:10.1038/nature18938 · Cited by 533
The TIM and TAM Families of Phosphatidylserine Receptors Mediate Dengue Virus Entry
Meertens, L., Carnec, X., Lecoin, M. P., Ramdasi, R., Guivel-Benhassine, F., Lew, E., Lemke, G., Schwartz, O., & Amara, A. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.08.009 · Cited by 524
Detection of Zika virus in saliva
Musso, D., Roche, C., Nhan, T.-X., Robin, E., Teissier, A., & Cao-Lormeau, V.-M. (2015) · Journal of Clinical Virology · doi:10.1016/j.jcv.2015.04.021 · Cited by 521
Dejnirattisai, W., Wongwiwat, W., Supasa, S., Zhang, X., Dai, X., Rouvinski, A., Jumnainsong, A., Edwards, C., Quyen, N. T. H., Duangchinda, T., et al. (2015) · Nature Immunology · doi:10.1038/ni.3058 · Cited by 500
A Screen of FDA-Approved Drugs for Inhibitors of Zika Virus Infection
Barrows, N. J., Campos, R. K., Powell, S. T., Prasanth, K. R., Schott-Lerner, G., Soto-Acosta, R., Galarza-Muñoz, G., McGrath, E. L., Urrabaz-Garza, R., Gao, J., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.07.004 · Cited by 497
Self-citationConformational Changes of the Flavivirus E Glycoprotein
Zhang, Y., Zhang, W., Ogata, S. A., Clements, D. E., Strauss, J. H., Baker, T. S., Kuhn, R. J., & Rossmann, M. G. (2004) · Structure · doi:10.1016/j.str.2004.06.019 · Cited by 480
Al-Bari, M. A. A. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv018 · Cited by 467
Characterization of a Novel Murine Model to Study Zika Virus
Rossi, S. L., Tesh, R. B., Azar, S. R., Muruato, A. E., Hanley, K. A., Auguste, A. J., Langsjoen, R. M., Paessler, S., Vasilakis, N., & Weaver, S. C. (2016) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0111 · Cited by 458
Self-citationThe Evolution and Emergence of RNA Viruses
Holmes, E. C. (2009) · doi:10.1093/oso/9780199211128.001.0001 · Cited by 452
THE USE OF YELLOW FEVER VIRUS MODIFIED BY IN VITRO CULTIVATION FOR HUMAN IMMUNIZATION
Theiler, M., & Smith, H. H. (1937) · Journal of Experimental Medicine · doi:10.1084/jem.65.6.787 · Cited by 445
Yap, T. L., Xu, T., Chen, Y.-L., Malet, H., Egloff, M.-P., Canard, B., Vasudevan, S. G., & Lescar, J. (2007) · Journal of Virology · doi:10.1128/jvi.02283-06 · Cited by 445
Mori, T., O'Keefe, B. R., Sowder, R. C., Bringans, S., Gardella, R., Berg, S., Cochran, P., Turpin, J. A., Buckheit, R. W., McMahon, J. B., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411122200 · Cited by 445
Mastrangelo, E., Pezzullo, M., De Burghgraeve, T., Kaptein, S., Pastorino, B., Dallmeier, K., de Lamballerie, X., Neyts, J., Hanson, A. M., Frick, D. N., et al. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks147 · Cited by 414
Kleber de Oliveira, W., Cortez-Escalante, J., De Oliveira, W. T. G. H., do Carmo, G. M. I., Henriques, C. M. P., Coelho, G. E., & Araújo de França, G. V. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6509e2 · Cited by 399
Glass, W. G., Lim, J. K., Cholera, R., Pletnev, A. G., Gao, J.-L., & Murphy, P. M. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042530 · Cited by 391
An adenosine nucleoside inhibitor of dengue virus
Yin, Z., Chen, Y.-L., Schul, W., Wang, Q.-Y., Gu, F., Duraiswamy, J., Kondreddi, R. R., Niyomrattanakit, P., Lakshminarayana, S. B., Goh, A., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907010106 · Cited by 390
Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen?
Mansuy, J. M., Dutertre, M., Mengelle, C., Fourcade, C., Marchou, B., Delobel, P., Izopet, J., & Martin-Blondel, G. (2016) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(16)00138-9 · Cited by 384
Field, H. J. (1988) · Cited by 383
Klimstra, W. B., Ryman, K. D., & Johnston, R. E. (1998) · Journal of Virology · doi:10.1128/jvi.72.9.7357-7366.1998 · Cited by 381
Crystal structure of Zika virus NS2B-NS3 protease in complex with a boronate inhibitor
Lei, J., Hansen, G., Nitsche, C., Klein, C. D., Zhang, L., & Hilgenfeld, R. (2016) · Science · doi:10.1126/science.aag2419 · Cited by 374
Self-citationSolution structure of dengue virus capsid protein reveals another fold
Ma, L., Jones, C. T., Groesch, T. D., Kuhn, R. J., & Post, C. B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305892101 · Cited by 372
Clinical Characteristics of the West Nile Fever Outbreak, Israel, 2000
Chowers, M., Lang, R., Nassar, F., David, D. B., Giladi, M., Rubinshtein, E., Itzhaki, A., Mishal, J., Siegman‐Igra, Y., Kitzes, R., et al. (2001) · Emerging infectious diseases · doi:10.3201/eid0704.010414 · Cited by 368
Jemielity, S., Wang, J. J., Chan, Y. K., Ahmed, A. A., Li, W., Monahan, S., Bu, X., Farzan, M., Freeman, G. J., Umetsu, D. T., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003232 · Cited by 364
Recognition determinants of broadly neutralizing human antibodies against dengue viruses
Rouvinski, A., Guardado-Calvo, P., Barba-Spaeth, G., Duquerroy, S., Vaney, M.-C., Kikuti, C. M., Navarro Sanchez, M. E., Dejnirattisai, W., Wongwiwat, W., Haouz, A., et al. (2015) · Nature · doi:10.1038/nature14130 · Cited by 357
Dengue Virus Infection Perturbs Lipid Homeostasis in Infected Mosquito Cells
Perera, R., Riley, C., Isaac, G., Hopf-Jannasch, A. S., Moore, R. J., Weitz, K. W., Pasa-Tolic, L., Metz, T. O., Adamec, J., & Kuhn, R. J. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002584 · Cited by 356
Murine Model for Dengue Virus-Induced Lethal Disease with IncreasedVascular Permeability
Shresta, S., Sharar, K. L., Prigozhin, D. M., Beatty, P. R., & Harris, E. (2006) · Journal of Virology · doi:10.1128/jvi.00062-06 · Cited by 353
Approval Summary for Bortezomib for Injection in the Treatment of Multiple Myeloma
Bross, P. F., Kane, R., Farrell, A. T., Abraham, S., Benson, K., Brower, M. E., Bradley, S., Gobburu, J. V., Goheer, A., Lee, S.-L., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0781 · Cited by 343
Development of difluoromethylornithine (DFMO) as a chemoprevention agent.
Meyskens, F. L., & Gerner, E. W. (1999) · PubMed · Cited by 337
Mycophenolic Acid: A One Hundred Year Odyssey from Antibiotic to Immunosuppressant
Bentley, R. (2000) · Chemical Reviews · doi:10.1021/cr990097b · Cited by 330
A Randomized Controlled Trial of Chloroquine for the Treatment of Dengue in Vietnamese Adults
Tricou, V., Minh, N. N., Van, T. P., Lee, S. J., Farrar, J., Wills, B., Tran, H. T., & Simmons, C. P. (2010) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000785 · Cited by 329
Tay, M. Y. F., Fraser, J. E., Chan, W. K. K., Moreland, N. J., Rathore, A. P., Wang, C., Vasudevan, S. G., & Jans, D. A. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.06.002 · Cited by 327
Male-to-Male Sexual Transmission of Zika Virus — Texas, January 2016
Deckard, D. T., Chung, W. M., Brooks, J. T., Smith, J. C., Woldai, S., Hennessey, M., Kwit, N., & Mead, P. (2016) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm6514a3 · Cited by 310
Pathogenesis of the Viral Hemorrhagic Fevers
Paessler, S., & Walker, D. H. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164041 · Cited by 309
Pathogenesis of Flavivirus Infections: Using and Abusing the Host Cell
Fernandez-Garcia, M.-D., Mazzon, M., Jacobs, M., & Amara, A. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.04.001 · Cited by 308
Detection of a trypsin-like serine protease domain in flaviviruses and pestviruses
Bazan, J. F., & Fletterick, R. J. (1989) · Virology · doi:10.1016/0042-6822(89)90639-9 · Cited by 307
Subcellular Localization and Membrane Topology of the Dengue Virus Type 2 Non-structural Protein 4B
Miller, S., Sparacio, S., & Bartenschlager, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512697200 · Cited by 302
Ligand-Bound Structures of the Dengue Virus Protease Reveal the Active Conformation
Noble, C. G., Seh, C. C., Chao, A. T., & Shi, P. Y. (2012) · Journal of Virology · doi:10.1128/jvi.06225-11 · Cited by 301
Castanospermine, a Potent Inhibitor of Dengue Virus Infection In Vitro and In Vivo
Whitby, K., Pierson, T. C., Geiss, B., Lane, K., Engle, M., Zhou, Y., Doms, R. W., & Diamond, M. S. (2005) · Journal of Virology · doi:10.1128/jvi.79.14.8698-8706.2005 · Cited by 295
Nguyen, N. M., Tran, C. N. B., Phung, L. K., Duong, K. T. H., Huynh, H. L. A., Farrar, J., Nguyen, Q. T. H., Tran, H. T., Nguyen, C. V. V., Merson, L., et al. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jis470 · Cited by 293
Zmurko, J., Marques, R. E., Schols, D., Verbeken, E., Kaptein, S. J. F., & Neyts, J. (2016) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004695 · Cited by 292
Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein
Luo, D., Xu, T., Watson, R. P., Scherer‐Becker, D., Sampath, A., Jahnke, W., Yeong, S. S., Wang, C. H., Lim, S. P., Strongin, A., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.232 · Cited by 271
Taguwa, S., Maringer, K., Li, X., Bernal-Rubio, D., Rauch, J. N., Gestwicki, J. E., Andino, R., Fernandez-Sesma, A., & Frydman, J. (2015) · Cell · doi:10.1016/j.cell.2015.10.046 · Cited by 270
Xiao, S.-Y., Guzman, H., Zhang, H., Travassos da Rosa, A. P. A., & Tesh, R. B. (2001) · Emerging Infectious Diseases · doi:10.3201/eid0704.010420 · Cited by 267
Broad-spectrum antiviral that interferes with de novo pyrimidine biosynthesis
Hoffmann, H.-H., Kunz, A., Simon, V. A., Palese, P., & Shaw, M. L. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1101143108 · Cited by 266
Crystal Structure of the West Nile Virus Envelope Glycoprotein
Nybakken, G. E., Nelson, C. A., Chen, B. R., Diamond, M. S., & Fremont, D. H. (2006) · Journal of Virology · doi:10.1128/jvi.01125-06 · Cited by 264
Analysis of Herpes Zoster Events Among Bortezomib-Treated Patients in the Phase III APEX Study
Chanan-Khan, A., Sonneveld, P., Schuster, M. W., Stadtmauer, E. A., Facon, T., Harousseau, J.-L., Ben-Yehuda, D., Lonial, S., Goldschmidt, H., Reece, D., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9641 · Cited by 263
Crystal Structure of the RNA Polymerase Domain of the West Nile Virus Non-structural Protein 5
Malet, H., Egloff, M.-P., Selisko, B., Butcher, R. E., Wright, P. J., Roberts, M., Gruez, A., Sulzenbacher, G., Vonrhein, C., Bricogne, G., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607273200 · Cited by 262
Low, J. G., Sung, C., Wijaya, L., Wei, Y., Rathore, A. P. S., Watanabe, S., Tan, B. H., Toh, L., Chua, L. T., Hou, Y., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70730-3 · Cited by 253
Haffizulla, J., Hartman, A., Hoppers, M., Resnick, H., Samudrala, S., Ginocchio, C., Bardin, M., & Rossignol, J.-F. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70717-0 · Cited by 251
Li, J., Lim, S. P., Beer, D., Patel, V., Wen, D., Tumanut, C., Tully, D. C., Williams, J. A., Jiricek, J., Priestle, J. P., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500588200 · Cited by 250
Schul, W., Liu, W., Xu, H., Flamand, M., & Vasudevan, S. G. (2007) · The Journal of Infectious Diseases · doi:10.1086/511310 · Cited by 246
Chambers, T. J., Grakoui, A., & Rice, C. M. (1991) · Journal of Virology · doi:10.1128/jvi.65.11.6042-6050.1991 · Cited by 243
The dengue virus NS5 protein as a target for drug discovery
Lim, S. P., Noble, C. G., & Shi, P.-Y. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.04.010 · Cited by 239
Benefits and risks of the Sanofi-Pasteur dengue vaccine: Modeling optimal deployment
Ferguson, N. M., Rodríguez-Barraquer, I., Dorigatti, I., Mier-y-Teran-Romero, L., Laydon, D. J., & Cummings, D. A. T. (2016) · Science · doi:10.1126/science.aaf9590 · Cited by 238
Crystal Structure of West Nile Virus Envelope Glycoprotein Reveals Viral Surface Epitopes
Kanai, R., Kar, K., Anthony, K., Gould, L. H., Ledizet, M., Fikrig, E., Marasco, W. A., Koski, R. A., & Modis, Y. (2006) · Journal of Virology · doi:10.1128/jvi.01735-06 · Cited by 235
Infectious Zika viral particles in breastmilk
Dupont-Rouzeyrol, M., Biron, A., O'Connor, O., Huguon, E., & Descloux, E. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00624-3 · Cited by 235
Rossignol, J. F., La Frazia, S., Chiappa, L., Ciucci, A., & Santoro, M. G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.029470 · Cited by 232
Gao, W. Y., Shirasaka, T., Johns, D. G., Broder, S., & Mitsuya, H. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116463 · Cited by 231
Structure and anti-dengue virus activity of sulfated polysaccharide from a marine alga
Hidari, K. I. P. J., Takahashi, N., Arihara, M., Nagaoka, M., Morita, K., & Suzuki, T. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.08.100 · Cited by 230
Flisiak, R., Feinman, S. V., Jablkowski, M., Horban, A., Kryczka, W., Pawlowska, M., Heathcote, J. E., Mazzella, G., Vandelli, C., Nicolas-Métral, V., et al. (2009) · Hepatology · doi:10.1002/hep.22835 · Cited by 227
The molecular basis of virulence of the encephalitogenic flaviviruses.
McMinn, P. C. (1997) · Journal of General Virology · doi:10.1099/0022-1317-78-11-2711 · Cited by 225
Bernard, K. A., Klimstra, W. B., & Johnston, R. E. (2000) · Virology · doi:10.1006/viro.2000.0546 · Cited by 223
Antiviral effects of an iminosugar derivative on flavivirus infections
Wu, S.-F., Lee, C.-J., Liao, C.-L., Dwek, R. A., Zitzmann, N., & Lin, Y.-L. (2002) · Journal of Virology · doi:10.1128/jvi.76.8.3596-3604.2002 · Cited by 220
LESCAR, J., LUO, D., XU, T., SAMPATH, A., LIM, S., CANARD, B., & VASUDEVAN, S. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.07.001 · Cited by 219
Structure and function of the Zika virus full-length NS5 protein
Zhao, B., Yi, G., Du, F., Chuang, Y.-C., Vaughan, R. C., Sankaran, B., Kao, C. C., & Li, P. (2017) · Nature Communications · doi:10.1038/ncomms14762 · Cited by 214
Courageot, M.-P., Frenkiel, M.-P., Duarte Dos Santos, C., Deubel, V., & Desprès, P. (2000) · Journal of Virology · doi:10.1128/jvi.74.1.564-572.2000 · Cited by 213
Metzner, K. J., Giulieri, S. G., Knoepfel, S. A., Rauch, P., Burgisser, P., Yerly, S., Günthard, H. F., & Cavassini, M. (2009) · Clinical Infectious Diseases · doi:10.1086/595703 · Cited by 212
Korba, B. E., Montero, A. B., Farrar, K., Gaye, K., Mukerjee, S., Ayers, M. S., & Rossignol, J.-F. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2007.08.005 · Cited by 210
Cellular Uptake of Antisense Morpholino Oligomers Conjugated to Arginine-Rich Peptides
Moulton, H. M., Nelson, M. H., Hatlevig, S. A., Reddy, M. T., & Iversen, P. L. (2004) · Bioconjugate Chemistry · doi:10.1021/bc034221g · Cited by 210
A Small-Molecule Dengue Virus Entry Inhibitor
Wang, Q.-Y., Patel, S. J., Vangrevelinghe, E., Xu, H. Y., Rao, R., Jaber, D., Schul, W., Gu, F., Heudi, O., Ma, N. L., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01148-08 · Cited by 210
Chao, C.-H., Chen, C.-M., Cheng, P.-L., Shih, J.-W., Tsou, A.-P., & Wu Lee, Y.-H. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2415 · Cited by 201
Antiviral drug discovery: broad-spectrum drugs from nature
Martinez, J. P., Sasse, F., Brönstrup, M., Diez, J., & Meyerhans, A. (2015) · Natural Product Reports · doi:10.1039/c4np00085d · Cited by 198
The flavivirus polymerase as a target for drug discovery
Malet, H., Massé, N., Selisko, B., Romette, J.-L., Alvarez, K., Guillemot, J. C., Tolou, H., Yap, T. L., Vasudevan, S. G., Lescar, J., et al. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.06.007 · Cited by 189
Small Molecule Inhibitors That Selectively Block Dengue Virus Methyltransferase
Lim, S. P., Sonntag, L., Noble, C. G., Nilar, S., Ng, R. H., Zou, G., Monaghan, P., Chung, K. Y., Dong, H., Liu, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179184 · Cited by 188
Youn, S., Li, T., McCune, B. T., Edeling, M. A., Fremont, D. H., Cristea, I. M., & Diamond, M. S. (2012) · Journal of Virology · doi:10.1128/jvi.00157-12 · Cited by 188
Lim, S. P., Noble, C. G., Seh, C. C., Soh, T. S., El Sahili, A., Chan, G. K. Y., Lescar, J., Arora, R., Benson, T., Nilar, S., et al. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005737 · Cited by 188
Antiviral effect of the heparan sulfate mimetic, PI-88, against dengue and encephalitic flaviviruses
Lee, E., Pavy, M., Young, N., Freeman, C., & Lobigs, M. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2005.08.006 · Cited by 185
ROSSIGNOL, J. ‐., & EL‐GOHARY, Y. M. (2006) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2006.03128.x · Cited by 180
Taylor, R., Kotian, P., Warren, T., Panchal, R., Bavari, S., Julander, J., Dobo, S., Rose, A., El-Kattan, Y., Taubenheim, B., et al. (2016) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2016.04.002 · Cited by 177
Ishikawa, T., Yamanaka, A., & Konishi, E. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.01.040 · Cited by 175
Neuroinvasive flavivirus infections
Sips, G. J., Wilschut, J., & Smit, J. M. (2012) · Reviews in Medical Virology · doi:10.1002/rmv.712 · Cited by 173
Martín-Acebes, M. A., Blázquez, A.-B., Jiménez de Oya, N., Escribano-Romero, E., & Saiz, J.-C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024970 · Cited by 172
Dokland, T., Walsh, M., Mackenzie, J. M., Khromykh, A. A., Ee, K.-H., & Wang, S. (2004) · Structure · doi:10.1016/j.str.2004.04.024 · Cited by 172
Egloff, M.-P., Decroly, E., Malet, H., Selisko, B., Benarroch, D., Ferron, F., & Canard, B. (2007) · Journal of Molecular Biology · doi:10.1016/j.jmb.2007.07.005 · Cited by 169
Martín-Acebes, M. A., Merino-Ramos, T., Blázquez, A.-B., Casas, J., Escribano-Romero, E., Sobrino, F., & Sáiz, J. (2014) · Journal of Virology · doi:10.1128/jvi.02061-14 · Cited by 165
Rathore, A. P. S., Paradkar, P. N., Watanabe, S., Tan, K. H., Sung, C., Connolly, J. E., Low, J., Ooi, E. E., & Vasudevan, S. G. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.10.002 · Cited by 165
Nitsche, C., Schreier, V. N., Behnam, M. A. M., Kumar, A., Bartenschlager, R. F. W., & Klein, C. D. P. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400828u · Cited by 163
Self-citationHolbrook, M. R. (2012) · Antiviral Research · doi:10.1016/j.antiviral.2012.10.005 · Cited by 161
Griffithsin Has Antiviral Activity against Hepatitis C Virus
Meuleman, P., Albecka, A., Belouzard, S., Vercauteren, K., Verhoye, L., Wychowski, C., Leroux-Roels, G., Palmer, K. E., & Dubuisson, J. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00633-11 · Cited by 160
A brief overview of mechanisms of mitochondrial toxicity from NRTIs
Kohler, J. J., & Lewis, W. (2007) · Environmental and Molecular Mutagenesis · doi:10.1002/em.20223 · Cited by 158
Biochemistry and Medicinal Chemistry of the Dengue Virus Protease
Nitsche, C., Holloway, S., Schirmeister, T., & Klein, C. D. (2014) · Chemical Reviews · doi:10.1021/cr500233q · Cited by 158
Self-citationNucleoside Inhibitors of Zika Virus
Eyer, L., Nencka, R., Huvarová, I., Palus, M., Alves, M. J., Gould, E. A., Clercq, E. D., & Růžek, D. (2016) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiw226 · Cited by 158
Tesh, R. B., Siirin, M., Guzmán, H., da Rosa, A. P. A. T., Wu, X., Duan, T., Lei, H. C., Nunes, M. R. T., & Xiao, S. (2005) · The Journal of Infectious Diseases · doi:10.1086/431153 · Cited by 157
Peptide–Boronic Acid Inhibitors of Flaviviral Proteases: Medicinal Chemistry and Structural Biology
Nitsche, C., Zhang, L., Weigel, L. F., Schilz, J., Graf, D., Bartenschlager, R. F. W., Hilgenfeld, R., & Klein, C. D. P. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01021 · Cited by 154
Self-citationHansson, M. J., Mattiasson, G., Månsson, R., Karlsson, J., Keep, M. F., Waldmeier, P. C., Rüegg, U. T., Dumont, J., Besseghir, K., & Elmér, E. (2004) · Journal of Bioenergetics and Biomembranes · doi:10.1023/b:jobb.0000041776.31885.45 · Cited by 146
Poh, M. K., Shui, G., Xie, X., Shi, P., Wenk, M. R., & Gu, F. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.11.014 · Cited by 145
A small molecule fusion inhibitor of dengue virus
Poh, M. K., Yip, A., Zhang, S. L.-X., Priestle, J. P., Ma, N. L., Smit, J. M., Wilschut, J., Shi, P., Wenk, M. R., & Schul, W. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.011 · Cited by 143
Richard, A. S., Zhang, A., Park, S.-J., Farzan, M., Zong, M., & Choe, H. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1508095112 · Cited by 140
Qing, M., Yang, F., Zhang, B., Zou, G., Robida, J. M., Yuan, Z., Tang, H., & Shi, P. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00189-09 · Cited by 138
Crystal structure of Zika virus NS5 RNA-dependent RNA polymerase
Godoy, A. S., Lima, G. M. A., de Oliveira, K. I. Z., Torres, N. U., Maluf, F. V., Guido, R. V. C., & Oliva, G. (2017) · Nature Communications · doi:10.1038/ncomms14764 · Cited by 134
In Vivo Pharmacological Effects of Ciclosporin and Some Analogues
Borel, J. F., Baumann, G., Chapman, I., Donatsch, P., Fahr, A., Mueller, E. A., & Vigouret, J. M. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60276-8 · Cited by 133
The Small Molecules AZD0530 and Dasatinib Inhibit Dengue Virus RNA Replication via Fyn Kinase
de Wispelaere, M., LaCroix, A. J., & Yang, P. L. (2013) · Journal of Virology · doi:10.1128/jvi.00632-13 · Cited by 130
Mounce, B. C., Poirier, E. Z., Passoni, G., Simon‐Lorière, E., Cesaro, T., Prot, M., Stapleford, K. A., Moratorio, G., Sakuntabhai, A., Levraud, J., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.06.011 · Cited by 128
Hydroxychloroquine-Inhibited Dengue Virus Is Associated with Host Defense Machinery
Wang, L.-F., Lin, Y.-S., Huang, N., Yu, C.-Y., Tsai, W.-L., Chen, J., Kubota, T., Matsuoka, M., Chen, S.-R., Yang, C.-S., et al. (2014) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0038 · Cited by 127
Possible West Nile Virus Transmission to an Infant Through Breast-Feeding--Michigan, 2002
(2002) · JAMA · doi:10.1001/jama.288.16.1976 · Cited by 127
Raaben, M., Posthuma, C. C., Verheije, M. H., Lintelo, E. G. T., Kikkert, M., Drijfhout, J. W., Snijder, E. J., Rottier, P. J. M., & de Haan, C. A. M. (2010) · Journal of Virology · doi:10.1128/jvi.00485-10 · Cited by 123
Behnam, M. A. M., Graf, D., Bartenschlager, R. F. W., Zlotos, D. P., & Klein, C. D. P. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01441 · Cited by 121
Self-citationBarton, C. R., Kouokam, J. C., Lasnik, A. B., Foreman, O., Cambon, A. C., Brock, G. N., Montefiori, D. C., Vojdani, F., McCormick, A. A., O’Keefe, B. R., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01407-13 · Cited by 120
Involvement of Ceramide in the Propagation of Japanese Encephalitis Virus
Tani, H., Shiokawa, M., Kaname, Y., Kambara, H., Mori, Y., Abe, T., Moriishi, K., & Matsuura, Y. (2010) · Journal of Virology · doi:10.1128/jvi.02499-09 · Cited by 120
Rawlinson, S. M., Pryor, M. J., Wright, P. J., & Jans, D. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808271200 · Cited by 119
Yang, C.-C., Hsieh, Y., Lee, S., Wu, S., Liao, C., Tsao, C., Chao, Y., Chern, J., Wu, C., & Yueh, A. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00855-10 · Cited by 119
Nall, T. A., Chappell, K. J., Stoermer, M. J., Fang, N.-X., Tyndall, J. D. A., Young, P. R., & Fairlie, D. P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406810200 · Cited by 116
Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance
Eltahla, A. A., Luciani, F., White, P. A., Lloyd, A. R., & Bull, R. A. (2015) · Viruses · doi:10.3390/v7102868 · Cited by 115
Squalamine as a broad-spectrum systemic antiviral agent with therapeutic potential
ZASLOFF, M. A., Adams, A. P., Beckerman, B., Campbell, A. E., Han, Z., Luijten, E., Meza, I., Julander, J. G., Mishra, A., Qu, W., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1108558108 · Cited by 115
Kampmann, T., Yennamalli, R. M., Campbell, P., Stoermer, M. J., Fairlie, D. P., Kobe, B., & Young, P. R. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.007 · Cited by 115
Dean, C. H., Alarcon, J. B., Waterston, A. M., et al. (2005) · Human Vaccines · doi:10.4161/hv.1.3.1797 · Cited by 113
Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity
Boonyasuppayakorn, S., Reichert, E. D., Manzano, M., Nagarajan, K., & Padmanabhan, R. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.03.014 · Cited by 111
Novel Benzoxazole Inhibitor of Dengue Virus Replication That Targets the NS3 Helicase
Byrd, C. M., Grosenbach, D. W., Berhanu, A., Dai, D., Jones, K. F., Cardwell, K. B., Schneider, C. A., Yang, G., Tyavanagimatt, S., Harver, C., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02251-12 · Cited by 110
The structure of Zika virus NS5 reveals a conserved domain conformation
Wang, B., Tan, X.-F., Thurmond, S., Zhang, Z., Lin, A., Hai, R., & Song, J. (2017) · Nature Communications · doi:10.1038/ncomms14763 · Cited by 110
Żmurko, J., Neyts, J. H., & Dallmeier, K. (2015) · Reviews in Medical Virology · doi:10.1002/rmv.1835 · Cited by 109
Weiskopf, D., Yauch, L. E., Angelo, M. A., John, D. V., Greenbaum, J., Sidney, J., Kolla, R. V., Silva, A. D. D., de Silva, A. M., Grey, H. M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101970 · Cited by 109
Breast Milk as a Possible Route of Vertical Transmission of Dengue Virus?
Barthel, A., Gourinat, A.-C., Cazorla, C., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit227 · Cited by 109
Characterization of Dengue Virus Resistance to Brequinar in Cell Culture
Qing, M., Zou, G., Wang, Q.-Y., Xu, H. Y., Dong, H., Yuan, Z., & Shi, P. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00561-10 · Cited by 109
Human DDX3 protein is a valuable target to develop broad spectrum antiviral agents
Brai, A., Fazi, R., Tintori, C., Zamperini, C., Bugli, F., Sanguinetti, M., Stigliano, E., Esté, J. A., Badía, R., Franco, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1522987113 · Cited by 108
Heil, M. L., Albee, A. J., Strauss, J. H., & Kuhn, R. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.14.6303-6309.2001 · Cited by 107
Discovery of Dengue Virus NS4B Inhibitors
Wang, Q.-Y., Dong, H., Zou, B., Karuna, R., Wan, K. F., Zou, J., Susila, A., Yip, A., Shan, C., Yeo, K. L., et al. (2015) · Journal of Virology · doi:10.1128/jvi.00855-15 · Cited by 106
Elazar, M., Liu, M. B., McKenna, S. A., Liu, P., Gehrig, E., Puglisi, J. D., Rossignol, J., & Glenn, J. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.07.056 · Cited by 104
Phenylalanine and Phenylglycine Analogues as Arginine Mimetics in Dengue Protease Inhibitors
Weigel, L. F., Nitsche, C., Graf, D., Bartenschlager, R. F. W., & Klein, C. D. P. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b00612 · Cited by 103
Self-citationPersistence of Japanese encephalitis virus in the human nervous system
Ravi, V., Desai, A. S., Shenoy, P. K., Satishchandra, P., Chandramuki, A., & Gourie‐Devi, M. (1993) · Journal of Medical Virology · doi:10.1002/jmv.1890400412 · Cited by 101
The Proteasome Inhibitor Bortezomib Enhances the Susceptibility to Viral Infection
Basler, M., Lauer, C., Beck, U., & Groettrup, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0901596 · Cited by 101
Martínez‐Gutierrez, M., Londoño, L. A. C., Castellanos, J. E., Gallego-Gómez, J. C., & Osorio, J. E. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087412 · Cited by 100
Smit, J. M., Waarts, B.-L., Kimata, K., Klimstra, W. B., Bittman, R., & Wilschut, J. (2002) · Journal of Virology · doi:10.1128/jvi.76.20.10128-10137.2002 · Cited by 100
BCX4430, a Novel Nucleoside Analog, Effectively Treats Yellow Fever in a Hamster Model
Julander, J. G., Bantia, S., Taubenheim, B. R., Minning, D. M., Kotian, P. L., Morrey, J. D., Smee, D. F., Sheridan, W. P., & Babu, Y. S. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03368-14 · Cited by 97
Celgosivir, an alpha-glucosidase I inhibitor for the potential treatment of HCV infection.
Durantel, D. (2009) · PubMed · Cited by 96
Characterization of the Mode of Action of a Potent Dengue Virus Capsid Inhibitor
Scaturro, P., Trist, I. M. L., Paul, D., Kumar, A., Acosta, E. G., Byrd, C. M., Jordan, R., Brancale, A., & Bartenschlager, R. F. W. (2014) · Journal of Virology · doi:10.1128/jvi.01745-14 · Cited by 96
An iminosugar with potent inhibition of dengue virus infection in vivo
Perry, S. T., Buck, M. D., Plummer, E. M., Penmasta, R., Batra, H., Stavale, E. J., Warfield, K. L., Dwek, R. A., Butters, T. D., Alonzi, D. S., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.01.004 · Cited by 93
In Vitro Resistance Selection and In Vivo Efficacy of Morpholino Oligomers against West Nile Virus
Deas, T. S., Bennett, C. J., Jones, S. A., Tilgner, M., Ren, P., Behr, M. J., Stein, D. A., Iversen, P. L., Kramer, L. D., Bernard, K. A., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00069-07 · Cited by 93
Fischl, M. A., Resnick, L., Coombs, R. W., Kremer, A. B., Pottage, J. C., Fass, R. J., Fife, K. H., Powderly, W. G., Collier, A. C., & Aspinall, R. L. (1994) · PubMed · Cited by 92
Targeting dengue virus NS4B protein for drug discovery
Xie, X., Zou, J., Wang, Q.-Y., & Shi, P. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.03.007 · Cited by 90
Small molecule inhibitors of ER α-glucosidases are active against multiple hemorrhagic fever viruses
Chang, J., Warren, T. K., Zhao, X., Gill, T., Guo, F., Wang, L., Comunale, M. A., Du, Y., Alonzi, D. S., Yu, W., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.03.023 · Cited by 89
Beck, A. S., Tesh, R. B., Wood, T. G., Widen, S. G., Ryman, K. D., & Barrett, A. D. T. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit546 · Cited by 89
Su, X., Ozawa, K., Qi, R., Vasudevan, S. G., Lim, S. P., & Otting, G. (2009) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0000561 · Cited by 89
Dengue Virus Tropism in Humanized Mice Recapitulates Human Dengue Fever
Mota, J., & Rico-Hesse, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020762 · Cited by 88
Activation of Peripheral Blood Mononuclear Cells by Dengue Virus Infection Depotentiates Balapiravir
Chen, Y., Ghafar, N. A., Karuna, R., Fu, Y., Lim, S. P., Schul, W., Gu, F., Herve, M., Yokohama, F., Wang, G., et al. (2013) · Journal of Virology · doi:10.1128/jvi.02841-13 · Cited by 88
Yang, C.-C., Hu, H.-S., Wu, R., Wu, S., Lee, S., Jiaang, W., Chern, J., Huang, Z.-S., Wu, H., Chang, C.-M., et al. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01281-13 · Cited by 88
High-Content Assay to Identify Inhibitors of Dengue Virus Infection
Shum, D., Smith, J. L., Hirsch, A. J., Bhinder, B., Radu, C., Stein, D. A., Nelson, J. A., Früh, K., & Djaballah, H. (2010) · Assay and Drug Development Technologies · doi:10.1089/adt.2010.0321 · Cited by 87
Novel Imino Sugar Derivatives Demonstrate Potent Antiviral Activity against Flaviviruses
Chang, J., Wang, L., Ma, D., Qu, X., Guo, H., Xu, X., Mason, P. M., Bourne, N., Moriarty, R. M., Gu, B., et al. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01457-08 · Cited by 87
Haile, W. B., Gavegnano, C., Tao, S., Jiang, Y., Schinazi, R. F., & Tyor, W. R. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.02.007 · Cited by 87
Stoermer, M. J., Chappell, K. J., Liebscher, S., Jensen, C. M., Gan, C. H., Gupta, P. K., Xu, W., Young, P. R., & Fairlie, D. P. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800503y · Cited by 86
Persistent Neuroinvasive West Nile Virus Infection in an Immunocompromised Patient
Penn, R. G., Guarner, J., Sejvar, J. J., Hartman, H., McComb, R. D., Nevins, D. L., Bhatnagar, J., & Zaki, S. R. (2006) · Clinical Infectious Diseases · doi:10.1086/500216 · Cited by 86
Griffithsin inhibits Japanese encephalitis virus infection in vitro and in vivo
Ishag, H. Z. A., Li, C., Huang, L., Sun, M., Wang, F., Ni, B., Malik, T., Chen, P., & Mao, X. (2012) · Archives of Virology · doi:10.1007/s00705-012-1489-2 · Cited by 85
Novel antiviral activity of bromocriptine against dengue virus replication
Kato, F., Ishida, Y., Oishi, S., Fujii, N., Watanabe, S., Vasudevan, S. G., Tajima, S., Takasaki, T., Suzuki, Y., Ichiyama, K., et al. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2016.04.014 · Cited by 85
Vernachio, J. H., Bleiman, B., Bryant, K. D., Chamberlain, S. D., Hunley, D., Hutchins, J. T., Ames, B., Gorovits, E., Ganguly, B., Hall, A. E., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01335-10 · Cited by 84
Peptide Inhibitors of West Nile NS3 Protease: SAR Study of Tetrapeptide Aldehyde Inhibitors
Knox, J. E., Ma, N. L., Yin, Z. Q., Patel, S. J., Wang, W., Chan, W.-L., Rao, K. R. R., Wang, G., Ngew, X., Patel, V., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0607606 · Cited by 83
Sexual transmission of Zika virus in Germany, April 2016
Frank, C., Cadar, D., Schlaphof, A., Neddersen, N., Günther, S., Schmidt‐Chanasit, J., & Tappe, D. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.23.30252 · Cited by 83
Anti‐Dengue‐Virus Activity and Structure–Activity Relationship Studies of Lycorine Derivatives
Wang, P., Li, L., Wang, Q., Shang, L., Shi, P., & Zheng, Y. (2014) · ChemMedChem · doi:10.1002/cmdc.201300505 · Cited by 82
The crystal structure of Zika virus helicase: basis for antiviral drug design
Tian, H., Ji, X., Yang, X., Xie, W., Yang, K., Chen, C., Wu, C., Chi, H., Mu, Z., Wang, Z., et al. (2016) · Protein & Cell · doi:10.1007/s13238-016-0275-4 · Cited by 82
Brain distribution of ribavirin after intranasal administration
Colombo, G., Lorenzini, L., Zironi, E., Galligioni, V., Sonvico, F., Balducci, A. G., Pagliuca, G., Giuliani, A., Calzà, L., & Scagliarini, A. (2011) · Antiviral Research · doi:10.1016/j.antiviral.2011.09.012 · Cited by 80
Watanabe, S., Chan, K. W. K., Dow, G. S., Ooi, E. E., Low, J. G. H., & Vasudevan, S. G. (2016) · Antiviral Research · doi:10.1016/j.antiviral.2015.12.008 · Cited by 79
Targeting Innate Immunity for Antiviral Therapy through Small Molecule Agonists of the RLR Pathway
Pattabhi, S., Wilkins, C. R., Dong, R., Knoll, M. L., Posakony, J., Kaiser, S. M., Mire, C. E., Wang, M. L., Ireton, R. C., Geisbert, T. W., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02202-15 · Cited by 78
Merino-Ramos, T., Vázquez-Calvo, Á., Casas, J., Sobrino, F., Sáiz, J., & Martín-Acebes, M. A. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01578-15 · Cited by 76
Perwitasari, O., Cho, H., Diamond, M., & Gale, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.285205 · Cited by 74
Chutes and ladders in hepatitis C nucleoside drug development
Coats, S. J., Garnier‐Amblard, E. C., Amblard, F., Ehteshami, M., Amiralaei, S., Zhang, H., Zhou, L., Bouclé, S., Lu, X., Bondada, L., et al. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.11.008 · Cited by 71
Cited by
Ruzek, D., Avšič Županc, T., Borde, J., Chrdle, A., Eyer, L., Karganova, G., Kholodilov, I., Knap, N., Kozlovskaya, L., Matveev, A., et al. (2019) · Antiviral Research · doi:10.1016/j.antiviral.2019.01.014 · Cited by 414
Rajter, J. C., Sherman, M. S., Fatteh, N., Vogel, F., Sacks, J., & Rajter, J.-J. (2021) · Chest · doi:10.1016/j.chest.2020.10.009 · Cited by 318
The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design
Rey, F. A., Stiasny, K., Vaney, M., Dellarole, M., & Heinz, F. X. (2018) · EMBO reports · doi:10.15252/embr.201745302 · Cited by 259
Current Status of COVID-19 Therapies and Drug Repositioning Applications
Altay, O., Mohammadi, E., Lam, S., Turkez, H., Boren, J., Nielsen, J., Uhlen, M., & Mardinoglu, A. (2020) · iScience · doi:10.1016/j.isci.2020.101303 · Cited by 98
Metadata
- Authors
- Boldescu, V., Behnam, M. A. M., Vasilakis, N., & Klein, C. D.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2017-05-05
- Volume
- 16
- Issue
- 8
- Pages
- 565-586
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2610396252
- Cited by
- 305
- References
- 245
- FWCI
- 6.74
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.